COST Action CA21116

  • Start of Action – 11/10/2022; End of Action – 10/10/2026
  • Theme Abstract

Identification of biological markers for prevention and translational medicine in pancreatic cancer (TRANSPAN)

Pancreatic cancer (PC) has a high mortality rate and is projected to become a massive public health problem in Europe. This Action will boost research on prevention of PC, particularly in the discovery of genetic risk factors, risk stratification, identification of biomarkers for early detection and patient monitoring, elucidation of biological mechanisms and functional pharmacogenomics for personalized medicine. These aims will be attained by expanding an existing interdisciplinary network.

Action CA21116 – COST